Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, Papakosta D, Antoniou K, Papanikolaou I, Steiropoulos P, Tomos I, Karampitsakos T, Levounets A, Fouka E, Spyropoulos G, Mastrodimou S, Papaioannou O, Kallieri M, Kosmidou N, Bizymi N, Zikos N, Dimeas I, Malli F, Daniil Z. Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients. Sarcoidosis, Vasculitis, And Diffuse Lung Diseases 2024, 41: e2024055. PMID: 39655591, DOI: 10.36141/svdld.v41i4.15661.Peer-Reviewed Original ResearchPET-CT findingsSarcoidosis patientsLikelihood of infectionInterstitial lung disease referral centersICU admissionPrevalence of SARS-CoV-2Younger ageSARS-CoV-2National multicenter studyGeneral populationInfection rateSARS-CoV-2 infectionPrevalence of SARS-CoV-2 infectionAdditional immunosuppressionCorticosteroid treatmentReferral centerMulticenter studySarcoidosisPatientsImmunosuppressionChance of infectionLonger diagnosisInfectionHospitalPrevalence